ImmunityBio (IBRX) Asset Utilization Ratio (2015 - 2026)
ImmunityBio (IBRX) posted quarterly Asset Utilization Ratio of 0.25 for Q1 2026, up 169.96% year-over-year from 0.09 in Q1 2025, and up 10.61% quarter-over-quarter from 0.22 in Q4 2025.
ImmunityBio (IBRX) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Asset Utilization Ratio for 12 consecutive years, with 0.25 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 169.96% year-over-year to 0.25; the TTM figure through Mar 2026 stood at 0.25 (up 169.96% YoY), while the FY2025 annual figure was 0.26, up 670.53% from the prior year.
- Asset Utilization Ratio improved to 0.25 in Q1 2026 per IBRX's latest filing, from 0.22 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.25 in Q1 2026 and bottomed at 0.0 in Q1 2024.
- Historically, Asset Utilization Ratio has averaged 0.06 across 5 years, with a median of 0.0 in 2022.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio tumbled 75.45% — and 2025, when it surged 13527.09%.
- ImmunityBio's Asset Utilization Ratio stood at 0.0 in 2022, then soared by 97.87% to 0.0 in 2023, then surged by 2871.13% to 0.04 in 2024, then surged by 462.57% to 0.22 in 2025, then climbed by 10.61% to 0.25 in 2026.
- Business Quant data shows IBRX's Asset Utilization Ratio at 0.25 in Q1 2026, 0.22 in Q4 2025, and 0.18 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | ImmunityBio | 7.97 Bn | 7.62 Bn | 50.94 Mn | 0.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.26 |
| Mar 31, 2026 | 0.25 |
| Dec 31, 2025 | 0.22 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.09 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |